Global mRNA Vaccine and Therapeutics Raw Material Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global mRNA Vaccine and Therapeutics Raw Material market size was estimated at USD 6042.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global mRNA Vaccine and Therapeutics Raw Material market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global mRNA Vaccine and Therapeutics Raw Material market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the mRNA Vaccine and Therapeutics Raw Material market.
Global mRNA Vaccine and Therapeutics Raw Material Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Jena Bioscience
Thermo Fisher Scientific Inc.
SBS Genetech
Sigma Aldrich
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
Etherna
Ethris
Tiba Biotechnology
Product Type Insights
Market Segmentation (by Type)
Infectious Disease Vaccines
Cancer Vaccine
Others
Market Segmentation (by Application)
Hospitals and Clinics
Outpatient and Surgery Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Vaccine and Therapeutics Raw Material Market
Overview of the regional outlook of the mRNA Vaccine and Therapeutics Raw Material Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccine and Therapeutics Raw Material Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Vaccine and Therapeutics Raw Material, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global mRNA Vaccine and Therapeutics Raw Material market size was estimated at USD 6042.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global mRNA Vaccine and Therapeutics Raw Material market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global mRNA Vaccine and Therapeutics Raw Material market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the mRNA Vaccine and Therapeutics Raw Material market.
Global mRNA Vaccine and Therapeutics Raw Material Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Jena Bioscience
Thermo Fisher Scientific Inc.
SBS Genetech
Sigma Aldrich
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
Etherna
Ethris
Tiba Biotechnology
Product Type Insights
Market Segmentation (by Type)
Infectious Disease Vaccines
Cancer Vaccine
Others
Market Segmentation (by Application)
Hospitals and Clinics
Outpatient and Surgery Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the mRNA Vaccine and Therapeutics Raw Material Market
Overview of the regional outlook of the mRNA Vaccine and Therapeutics Raw Material Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccine and Therapeutics Raw Material Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Vaccine and Therapeutics Raw Material, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Vaccine and Therapeutics Raw Material
1.2 Key Market Segments
1.2.1 mRNA Vaccine and Therapeutics Raw Material Segment by Type
1.2.2 mRNA Vaccine and Therapeutics Raw Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Vaccine and Therapeutics Raw Material Product Life Cycle
3.3 Global mRNA Vaccine and Therapeutics Raw Material Sales by Manufacturers (2020-2025)
3.4 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Vaccine and Therapeutics Raw Material Market Competitive Situation and Trends
3.8.1 mRNA Vaccine and Therapeutics Raw Material Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Vaccine and Therapeutics Raw Material Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL INDUSTRY CHAIN ANALYSIS
4.1 mRNA Vaccine and Therapeutics Raw Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Vaccine and Therapeutics Raw Material Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Vaccine and Therapeutics Raw Material Market
5.7 ESG Ratings of Leading Companies
6 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2025)
6.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (2020-2025)
6.4 Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2020-2025)
7 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccine and Therapeutics Raw Material Market Sales by Application (2020-2025)
7.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2020-2025)
8 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET SALES BY REGION
8.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region
8.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.2.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.2.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.3 North America
8.3.1 North America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.3.2 North America mRNA Vaccine and Therapeutics Raw Material Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.4.2 Europe mRNA Vaccine and Therapeutics Raw Material Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.5.2 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.6.2 South America mRNA Vaccine and Therapeutics Raw Material Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.7.2 Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Vaccine and Therapeutics Raw Material by Region(2020-2025)
9.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Vaccine and Therapeutics Raw Material Production
9.4.1 North America mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.4.2 North America mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Vaccine and Therapeutics Raw Material Production
9.5.1 Europe mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Vaccine and Therapeutics Raw Material Production (2020-2025)
9.6.1 Japan mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Vaccine and Therapeutics Raw Material Production (2020-2025)
9.7.1 China mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.7.2 China mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Jena Bioscience
10.1.1 Jena Bioscience Basic Information
10.1.2 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
10.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.1.4 Jena Bioscience Business Overview
10.1.5 Jena Bioscience SWOT Analysis
10.1.6 Jena Bioscience Recent Developments
10.2 Thermo Fisher Scientific Inc.
10.2.1 Thermo Fisher Scientific Inc. Basic Information
10.2.2 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
10.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.2.4 Thermo Fisher Scientific Inc. Business Overview
10.2.5 Thermo Fisher Scientific Inc. SWOT Analysis
10.2.6 Thermo Fisher Scientific Inc. Recent Developments
10.3 SBS Genetech
10.3.1 SBS Genetech Basic Information
10.3.2 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
10.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.3.4 SBS Genetech Business Overview
10.3.5 SBS Genetech SWOT Analysis
10.3.6 SBS Genetech Recent Developments
10.4 Sigma Aldrich
10.4.1 Sigma Aldrich Basic Information
10.4.2 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
10.4.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.4.4 Sigma Aldrich Business Overview
10.4.5 Sigma Aldrich Recent Developments
10.5 Moderna Therapeutics
10.5.1 Moderna Therapeutics Basic Information
10.5.2 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
10.5.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.5.4 Moderna Therapeutics Business Overview
10.5.5 Moderna Therapeutics Recent Developments
10.6 CureVac
10.6.1 CureVac Basic Information
10.6.2 CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
10.6.3 CureVac mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Translate Bio
10.7.1 Translate Bio Basic Information
10.7.2 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
10.7.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.7.4 Translate Bio Business Overview
10.7.5 Translate Bio Recent Developments
10.8 BioNTech
10.8.1 BioNTech Basic Information
10.8.2 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
10.8.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Sangamo Therapeutics
10.9.1 Sangamo Therapeutics Basic Information
10.9.2 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
10.9.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.9.4 Sangamo Therapeutics Business Overview
10.9.5 Sangamo Therapeutics Recent Developments
10.10 Argos Therapeutics
10.10.1 Argos Therapeutics Basic Information
10.10.2 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
10.10.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.10.4 Argos Therapeutics Business Overview
10.10.5 Argos Therapeutics Recent Developments
10.11 In-Cell-Art
10.11.1 In-Cell-Art Basic Information
10.11.2 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
10.11.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.11.4 In-Cell-Art Business Overview
10.11.5 In-Cell-Art Recent Developments
10.12 Etherna
10.12.1 Etherna Basic Information
10.12.2 Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
10.12.3 Etherna mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.12.4 Etherna Business Overview
10.12.5 Etherna Recent Developments
10.13 Ethris
10.13.1 Ethris Basic Information
10.13.2 Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
10.13.3 Ethris mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.13.4 Ethris Business Overview
10.13.5 Ethris Recent Developments
10.14 Tiba Biotechnology
10.14.1 Tiba Biotechnology Basic Information
10.14.2 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
10.14.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.14.4 Tiba Biotechnology Business Overview
10.14.5 Tiba Biotechnology Recent Developments
10.15 Product Type Insights
10.15.1 Product Type Insights Basic Information
10.15.2 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
10.15.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.15.4 Product Type Insights Business Overview
10.15.5 Product Type Insights Recent Developments
11 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET FORECAST BY REGION
11.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast
11.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region
11.2.4 South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Vaccine and Therapeutics Raw Material by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of mRNA Vaccine and Therapeutics Raw Material by Type (2026-2035)
12.1.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of mRNA Vaccine and Therapeutics Raw Material by Type (2026-2035)
12.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Application (2026-2035)
12.2.1 Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) Forecast by Application
12.2.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA Vaccine and Therapeutics Raw Material
1.2 Key Market Segments
1.2.1 mRNA Vaccine and Therapeutics Raw Material Segment by Type
1.2.2 mRNA Vaccine and Therapeutics Raw Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Vaccine and Therapeutics Raw Material Product Life Cycle
3.3 Global mRNA Vaccine and Therapeutics Raw Material Sales by Manufacturers (2020-2025)
3.4 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Vaccine and Therapeutics Raw Material Market Competitive Situation and Trends
3.8.1 mRNA Vaccine and Therapeutics Raw Material Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Vaccine and Therapeutics Raw Material Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL INDUSTRY CHAIN ANALYSIS
4.1 mRNA Vaccine and Therapeutics Raw Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Vaccine and Therapeutics Raw Material Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Vaccine and Therapeutics Raw Material Market
5.7 ESG Ratings of Leading Companies
6 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2025)
6.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (2020-2025)
6.4 Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2020-2025)
7 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccine and Therapeutics Raw Material Market Sales by Application (2020-2025)
7.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2020-2025)
8 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET SALES BY REGION
8.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region
8.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.2.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.2.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.3 North America
8.3.1 North America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.3.2 North America mRNA Vaccine and Therapeutics Raw Material Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.4.2 Europe mRNA Vaccine and Therapeutics Raw Material Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.5.2 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.6.2 South America mRNA Vaccine and Therapeutics Raw Material Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.7.2 Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Vaccine and Therapeutics Raw Material by Region(2020-2025)
9.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Vaccine and Therapeutics Raw Material Production
9.4.1 North America mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.4.2 North America mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Vaccine and Therapeutics Raw Material Production
9.5.1 Europe mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Vaccine and Therapeutics Raw Material Production (2020-2025)
9.6.1 Japan mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Vaccine and Therapeutics Raw Material Production (2020-2025)
9.7.1 China mRNA Vaccine and Therapeutics Raw Material Production Growth Rate (2020-2025)
9.7.2 China mRNA Vaccine and Therapeutics Raw Material Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Jena Bioscience
10.1.1 Jena Bioscience Basic Information
10.1.2 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
10.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.1.4 Jena Bioscience Business Overview
10.1.5 Jena Bioscience SWOT Analysis
10.1.6 Jena Bioscience Recent Developments
10.2 Thermo Fisher Scientific Inc.
10.2.1 Thermo Fisher Scientific Inc. Basic Information
10.2.2 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
10.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.2.4 Thermo Fisher Scientific Inc. Business Overview
10.2.5 Thermo Fisher Scientific Inc. SWOT Analysis
10.2.6 Thermo Fisher Scientific Inc. Recent Developments
10.3 SBS Genetech
10.3.1 SBS Genetech Basic Information
10.3.2 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
10.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.3.4 SBS Genetech Business Overview
10.3.5 SBS Genetech SWOT Analysis
10.3.6 SBS Genetech Recent Developments
10.4 Sigma Aldrich
10.4.1 Sigma Aldrich Basic Information
10.4.2 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
10.4.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.4.4 Sigma Aldrich Business Overview
10.4.5 Sigma Aldrich Recent Developments
10.5 Moderna Therapeutics
10.5.1 Moderna Therapeutics Basic Information
10.5.2 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
10.5.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.5.4 Moderna Therapeutics Business Overview
10.5.5 Moderna Therapeutics Recent Developments
10.6 CureVac
10.6.1 CureVac Basic Information
10.6.2 CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
10.6.3 CureVac mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Translate Bio
10.7.1 Translate Bio Basic Information
10.7.2 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
10.7.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.7.4 Translate Bio Business Overview
10.7.5 Translate Bio Recent Developments
10.8 BioNTech
10.8.1 BioNTech Basic Information
10.8.2 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
10.8.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Sangamo Therapeutics
10.9.1 Sangamo Therapeutics Basic Information
10.9.2 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
10.9.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.9.4 Sangamo Therapeutics Business Overview
10.9.5 Sangamo Therapeutics Recent Developments
10.10 Argos Therapeutics
10.10.1 Argos Therapeutics Basic Information
10.10.2 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
10.10.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.10.4 Argos Therapeutics Business Overview
10.10.5 Argos Therapeutics Recent Developments
10.11 In-Cell-Art
10.11.1 In-Cell-Art Basic Information
10.11.2 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
10.11.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.11.4 In-Cell-Art Business Overview
10.11.5 In-Cell-Art Recent Developments
10.12 Etherna
10.12.1 Etherna Basic Information
10.12.2 Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
10.12.3 Etherna mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.12.4 Etherna Business Overview
10.12.5 Etherna Recent Developments
10.13 Ethris
10.13.1 Ethris Basic Information
10.13.2 Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
10.13.3 Ethris mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.13.4 Ethris Business Overview
10.13.5 Ethris Recent Developments
10.14 Tiba Biotechnology
10.14.1 Tiba Biotechnology Basic Information
10.14.2 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
10.14.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.14.4 Tiba Biotechnology Business Overview
10.14.5 Tiba Biotechnology Recent Developments
10.15 Product Type Insights
10.15.1 Product Type Insights Basic Information
10.15.2 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
10.15.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Market Performance
10.15.4 Product Type Insights Business Overview
10.15.5 Product Type Insights Recent Developments
11 MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MARKET FORECAST BY REGION
11.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast
11.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region
11.2.4 South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Vaccine and Therapeutics Raw Material by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of mRNA Vaccine and Therapeutics Raw Material by Type (2026-2035)
12.1.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of mRNA Vaccine and Therapeutics Raw Material by Type (2026-2035)
12.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Application (2026-2035)
12.2.1 Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) Forecast by Application
12.2.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (M USD)
Table 4. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application
Table 5. mRNA Vaccine and Therapeutics Raw Material Market Size Comparison by Region (M USD)
Table 6. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Vaccine and Therapeutics Raw Material Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Vaccine and Therapeutics Raw Material Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine and Therapeutics Raw Material as of 2025)
Table 11. Global Market mRNA Vaccine and Therapeutics Raw Material Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global mRNA Vaccine and Therapeutics Raw Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccine and Therapeutics Raw Material Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global mRNA Vaccine and Therapeutics Raw Material Sales by Type (K MT)
Table 27. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (M USD)
Table 28. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) by Type (2020-2025)
Table 29. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2025)
Table 30. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Type (2020-2025)
Table 31. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Type (2020-2025)
Table 32. Global mRNA Vaccine and Therapeutics Raw Material Price (USD/KG) by Type (2020-2025)
Table 33. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) by Application
Table 34. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application
Table 35. Global mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2025) & (K MT)
Table 36. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2025)
Table 37. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application (2020-2025) & (M USD)
Table 38. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application (2020-2025)
Table 39. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2020-2025)
Table 40. Global mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2025) & (K MT)
Table 41. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2020-2025)
Table 42. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025) & (M USD)
Table 43. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025)
Table 44. North America mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2025) & (K MT)
Table 45. North America mRNA Vaccine and Therapeutics Raw Material Market Size by Country (2020-2025) & (M USD)
Table 46. Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2025) & (K MT)
Table 47. Europe mRNA Vaccine and Therapeutics Raw Material Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025) & (M USD)
Table 50. South America mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2025) & (K MT)
Table 51. South America mRNA Vaccine and Therapeutics Raw Material Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025) & (M USD)
Table 54. Global mRNA Vaccine and Therapeutics Raw Material Production (K MT) by Region(2020-2025)
Table 55. Global mRNA Vaccine and Therapeutics Raw Material Revenue (US$ Million) by Region (2020-2025)
Table 56. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Region (2020-2025)
Table 57. Global mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Jena Bioscience Basic Information
Table 63. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 64. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Jena Bioscience Business Overview
Table 66. Jena Bioscience SWOT Analysis
Table 67. Jena Bioscience Recent Developments
Table 68. Thermo Fisher Scientific Inc. Basic Information
Table 69. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 70. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Scientific Inc. Business Overview
Table 72. Thermo Fisher Scientific Inc. SWOT Analysis
Table 73. Thermo Fisher Scientific Inc. Recent Developments
Table 74. SBS Genetech Basic Information
Table 75. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 76. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. SBS Genetech Business Overview
Table 78. SBS Genetech SWOT Analysis
Table 79. SBS Genetech Recent Developments
Table 80. Sigma Aldrich Basic Information
Table 81. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 82. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sigma Aldrich Business Overview
Table 84. Sigma Aldrich Recent Developments
Table 85. Moderna Therapeutics Basic Information
Table 86. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 87. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Moderna Therapeutics Business Overview
Table 89. Moderna Therapeutics Recent Developments
Table 90. CureVac Basic Information
Table 91. CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 92. CureVac mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. CureVac Business Overview
Table 94. CureVac Recent Developments
Table 95. Translate Bio Basic Information
Table 96. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 97. Translate Bio mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Translate Bio Business Overview
Table 99. Translate Bio Recent Developments
Table 100. BioNTech Basic Information
Table 101. BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 102. BioNTech mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BioNTech Business Overview
Table 104. BioNTech Recent Developments
Table 105. Sangamo Therapeutics Basic Information
Table 106. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 107. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sangamo Therapeutics Business Overview
Table 109. Sangamo Therapeutics Recent Developments
Table 110. Argos Therapeutics Basic Information
Table 111. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 112. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Argos Therapeutics Business Overview
Table 114. Argos Therapeutics Recent Developments
Table 115. In-Cell-Art Basic Information
Table 116. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 117. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. In-Cell-Art Business Overview
Table 119. In-Cell-Art Recent Developments
Table 120. Etherna Basic Information
Table 121. Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 122. Etherna mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Etherna Business Overview
Table 124. Etherna Recent Developments
Table 125. Ethris Basic Information
Table 126. Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 127. Ethris mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Ethris Business Overview
Table 129. Ethris Recent Developments
Table 130. Tiba Biotechnology Basic Information
Table 131. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 132. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Tiba Biotechnology Business Overview
Table 134. Tiba Biotechnology Recent Developments
Table 135. Product Type Insights Basic Information
Table 136. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 137. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Product Type Insights Business Overview
Table 139. Product Type Insights Recent Developments
Table 140. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global mRNA Vaccine and Therapeutics Raw Material Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (M USD)
Table 4. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application
Table 5. mRNA Vaccine and Therapeutics Raw Material Market Size Comparison by Region (M USD)
Table 6. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Vaccine and Therapeutics Raw Material Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Vaccine and Therapeutics Raw Material Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine and Therapeutics Raw Material as of 2025)
Table 11. Global Market mRNA Vaccine and Therapeutics Raw Material Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global mRNA Vaccine and Therapeutics Raw Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccine and Therapeutics Raw Material Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global mRNA Vaccine and Therapeutics Raw Material Sales by Type (K MT)
Table 27. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Type (M USD)
Table 28. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) by Type (2020-2025)
Table 29. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2020-2025)
Table 30. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Type (2020-2025)
Table 31. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Type (2020-2025)
Table 32. Global mRNA Vaccine and Therapeutics Raw Material Price (USD/KG) by Type (2020-2025)
Table 33. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) by Application
Table 34. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application
Table 35. Global mRNA Vaccine and Therapeutics Raw Material Sales by Application (2020-2025) & (K MT)
Table 36. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2025)
Table 37. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Application (2020-2025) & (M USD)
Table 38. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application (2020-2025)
Table 39. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2020-2025)
Table 40. Global mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2025) & (K MT)
Table 41. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2020-2025)
Table 42. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025) & (M USD)
Table 43. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025)
Table 44. North America mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2025) & (K MT)
Table 45. North America mRNA Vaccine and Therapeutics Raw Material Market Size by Country (2020-2025) & (M USD)
Table 46. Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2025) & (K MT)
Table 47. Europe mRNA Vaccine and Therapeutics Raw Material Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025) & (M USD)
Table 50. South America mRNA Vaccine and Therapeutics Raw Material Sales by Country (2020-2025) & (K MT)
Table 51. South America mRNA Vaccine and Therapeutics Raw Material Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025) & (M USD)
Table 54. Global mRNA Vaccine and Therapeutics Raw Material Production (K MT) by Region(2020-2025)
Table 55. Global mRNA Vaccine and Therapeutics Raw Material Revenue (US$ Million) by Region (2020-2025)
Table 56. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Region (2020-2025)
Table 57. Global mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China mRNA Vaccine and Therapeutics Raw Material Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Jena Bioscience Basic Information
Table 63. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 64. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Jena Bioscience Business Overview
Table 66. Jena Bioscience SWOT Analysis
Table 67. Jena Bioscience Recent Developments
Table 68. Thermo Fisher Scientific Inc. Basic Information
Table 69. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 70. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Scientific Inc. Business Overview
Table 72. Thermo Fisher Scientific Inc. SWOT Analysis
Table 73. Thermo Fisher Scientific Inc. Recent Developments
Table 74. SBS Genetech Basic Information
Table 75. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 76. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. SBS Genetech Business Overview
Table 78. SBS Genetech SWOT Analysis
Table 79. SBS Genetech Recent Developments
Table 80. Sigma Aldrich Basic Information
Table 81. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 82. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sigma Aldrich Business Overview
Table 84. Sigma Aldrich Recent Developments
Table 85. Moderna Therapeutics Basic Information
Table 86. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 87. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Moderna Therapeutics Business Overview
Table 89. Moderna Therapeutics Recent Developments
Table 90. CureVac Basic Information
Table 91. CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 92. CureVac mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. CureVac Business Overview
Table 94. CureVac Recent Developments
Table 95. Translate Bio Basic Information
Table 96. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 97. Translate Bio mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Translate Bio Business Overview
Table 99. Translate Bio Recent Developments
Table 100. BioNTech Basic Information
Table 101. BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 102. BioNTech mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BioNTech Business Overview
Table 104. BioNTech Recent Developments
Table 105. Sangamo Therapeutics Basic Information
Table 106. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 107. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sangamo Therapeutics Business Overview
Table 109. Sangamo Therapeutics Recent Developments
Table 110. Argos Therapeutics Basic Information
Table 111. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 112. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Argos Therapeutics Business Overview
Table 114. Argos Therapeutics Recent Developments
Table 115. In-Cell-Art Basic Information
Table 116. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 117. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. In-Cell-Art Business Overview
Table 119. In-Cell-Art Recent Developments
Table 120. Etherna Basic Information
Table 121. Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 122. Etherna mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Etherna Business Overview
Table 124. Etherna Recent Developments
Table 125. Ethris Basic Information
Table 126. Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 127. Ethris mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Ethris Business Overview
Table 129. Ethris Recent Developments
Table 130. Tiba Biotechnology Basic Information
Table 131. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 132. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Tiba Biotechnology Business Overview
Table 134. Tiba Biotechnology Recent Developments
Table 135. Product Type Insights Basic Information
Table 136. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
Table 137. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Product Type Insights Business Overview
Table 139. Product Type Insights Recent Developments
Table 140. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global mRNA Vaccine and Therapeutics Raw Material Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA Vaccine and Therapeutics Raw Material
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD), 2025-2035
Figure 5. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) (2020-2035)
Figure 6. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccine and Therapeutics Raw Material Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Vaccine and Therapeutics Raw Material Product Life Cycle
Figure 13. mRNA Vaccine and Therapeutics Raw Material Sales Share by Manufacturers in 2025
Figure 14. Global mRNA Vaccine and Therapeutics Raw Material Revenue Share by Manufacturers in 2025
Figure 15. mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market mRNA Vaccine and Therapeutics Raw Material Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine and Therapeutics Raw Material Revenue in 2025
Figure 18. Industry Chain Map of mRNA Vaccine and Therapeutics Raw Material
Figure 19. Global mRNA Vaccine and Therapeutics Raw Material Market PEST Analysis
Figure 20. Global mRNA Vaccine and Therapeutics Raw Material Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Type
Figure 27. Sales Market Share of mRNA Vaccine and Therapeutics Raw Material by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Vaccine and Therapeutics Raw Material by Type in 2025
Figure 29. Market Share of mRNA Vaccine and Therapeutics Raw Material by Type (2020-2025)
Figure 30. Market Share of mRNA Vaccine and Therapeutics Raw Material by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application
Figure 33. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application in 2025
Figure 35. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application (2020-2025)
Figure 36. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application in 2025
Figure 37. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025)
Figure 40. North America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 43. North America mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Vaccine and Therapeutics Raw Material Market Size by Country in 2024
Figure 45. U.S. mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Vaccine and Therapeutics Raw Material Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Vaccine and Therapeutics Raw Material Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Vaccine and Therapeutics Raw Material Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 53. Europe mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Vaccine and Therapeutics Raw Material Market Size by Country in 2024
Figure 55. Germany mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (K MT)
Figure 66. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size by Region in 2024
Figure 68. China mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (K MT)
Figure 79. South America mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 80. South America mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Vaccine and Therapeutics Raw Material Market Size by Country in 2024
Figure 82. Brazil mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size by Region in 2024
Figure 92. Saudi Arabia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 106. China mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 107. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global mRNA Vaccine and Therapeutics Raw Material Market Share Forecast by Type (2026-2035)
Figure 111. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Application (2026-2035)
Figure 112. Global mRNA Vaccine and Therapeutics Raw Material Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of mRNA Vaccine and Therapeutics Raw Material
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD), 2025-2035
Figure 5. Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) (2020-2035)
Figure 6. Global mRNA Vaccine and Therapeutics Raw Material Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccine and Therapeutics Raw Material Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Vaccine and Therapeutics Raw Material Product Life Cycle
Figure 13. mRNA Vaccine and Therapeutics Raw Material Sales Share by Manufacturers in 2025
Figure 14. Global mRNA Vaccine and Therapeutics Raw Material Revenue Share by Manufacturers in 2025
Figure 15. mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market mRNA Vaccine and Therapeutics Raw Material Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine and Therapeutics Raw Material Revenue in 2025
Figure 18. Industry Chain Map of mRNA Vaccine and Therapeutics Raw Material
Figure 19. Global mRNA Vaccine and Therapeutics Raw Material Market PEST Analysis
Figure 20. Global mRNA Vaccine and Therapeutics Raw Material Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Type
Figure 27. Sales Market Share of mRNA Vaccine and Therapeutics Raw Material by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Vaccine and Therapeutics Raw Material by Type in 2025
Figure 29. Market Share of mRNA Vaccine and Therapeutics Raw Material by Type (2020-2025)
Figure 30. Market Share of mRNA Vaccine and Therapeutics Raw Material by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application
Figure 33. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Application in 2025
Figure 35. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application (2020-2025)
Figure 36. Global mRNA Vaccine and Therapeutics Raw Material Market Share by Application in 2025
Figure 37. Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Vaccine and Therapeutics Raw Material Market Size by Region (2020-2025)
Figure 40. North America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 43. North America mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Vaccine and Therapeutics Raw Material Market Size by Country in 2024
Figure 45. U.S. mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Vaccine and Therapeutics Raw Material Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Vaccine and Therapeutics Raw Material Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Vaccine and Therapeutics Raw Material Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 53. Europe mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Vaccine and Therapeutics Raw Material Market Size by Country in 2024
Figure 55. Germany mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (K MT)
Figure 66. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size by Region in 2024
Figure 68. China mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (K MT)
Figure 79. South America mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Country in 2024
Figure 80. South America mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Vaccine and Therapeutics Raw Material Market Size by Country in 2024
Figure 82. Brazil mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Market Size by Region in 2024
Figure 92. Saudi Arabia mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Vaccine and Therapeutics Raw Material Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa mRNA Vaccine and Therapeutics Raw Material Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 106. China mRNA Vaccine and Therapeutics Raw Material Production (K MT) Growth Rate (2020-2025)
Figure 107. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global mRNA Vaccine and Therapeutics Raw Material Market Share Forecast by Type (2026-2035)
Figure 111. Global mRNA Vaccine and Therapeutics Raw Material Sales Forecast by Application (2026-2035)
Figure 112. Global mRNA Vaccine and Therapeutics Raw Material Market Share Forecast by Application (2026-2035)
